During maintenance, your dose remains consistent week-to-week, allowing your body to sustain appetite reduction and improve insulin sensitivity without constant adjustment
The quality evidence of TST90, weight, waist circumference, weight% change, SBP, DBP, TC, LDL, serious adverse events, and non-serious adverse events was moderate
Schedule an appointment with Dr
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3)
You may be a candidate for medical weight loss with Semaglutide if you have a body mass index (BMI) of 27 or higher and have weight-related health issues, or if your BMI is 30 or higher
What Patients Should Know Patients considering GLP-1 medications should remember: Weight Loss May Helpbut Results Vary Every lymphatic system is different